Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Name: Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma
Published: 2010
License: Public Domain

Celgene · 2010

ClinicalTrials.gov · Datasets · License: Public Domain · 2010

Open Source ↗

hepatocellular-carcinoma multiple-myeloma non-small-cell-lung-cancer

multiple myeloma, diffuse large b-cell lymphoma, glioblastoma multiforme, hepatocellular carcinoma, non-small cell lung cancer, neuroendocrine tumors of non-pancreatic origin, hormone receptor-positive breast cancer, advanced solid malignant neoplasms,non-hodgkin lymphoma,, interventional, phase1, phase2

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma or Multiple Myeloma

Related documents